Description:
Southwest Oncology Group S0600 Prestudy Form Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=153FB385-1447-52C3-E044-0003BA3F9857
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=153FB385-1447-52C3-E044-0003BA3F9857Keywords:
Versions (4)
- 8/27/12 8/27/12 -
- 8/8/14 8/8/14 - Martin Dugas
- 1/9/15 1/9/15 - Martin Dugas
- 8/5/15 8/5/15 - Martin Dugas
Uploaded on:
August 5, 2015
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
No Instruction available.
- StudyEvent: Southwest Oncology Group S0600 Prestudy Form